The President’s Emergency Plan for AIDS Relief (PEPFAR), a federal program that provides HIV medications, is one of the programs on pause during a 90-day review ordered by the Secretary of State.

The United States has approved an emergency humanitarian waiver allowing continued access to HIV treatment funded by the U.S. across 55 countries worldwide including Kenya. On January 29, 2025, U.S. Secretary of State Marco Rubio authorized the waiver,

Secretary of State Marco Rubio’s order to pause nearly all foreign aid has halted funding to the President’s Emergency Plan for AIDS Relief (PEPFAR), an African HIV-prevention program launched by President George W.

Leaders of the global fight against HIV/AIDS let out a sigh of relief on Wednesday as the Donald Trump administration scaled back – at least temporarily – one of the most damaging policies of its first days in office.

The State Department has frozen new funding for almost all U.S. aid programs worldwide, making exceptions to allow humanitarian food programs and military aid to Israel and Egypt to continue.

The Trump administration’s executive order pausing foreign aid programs has sent crash waves through relief organizations such as the United States Agency for International Development (USAID), whi | Under an executive order,

On Friday, a memorandum signed by Marco Rubio called for a 90-day cessation of foreign aid. That would likely put on hold the work of PEPFAR, the President's Emergency Plan for AIDS Relief.

Laurus Labs stock declined by more than 15 per cent on Monday following the U.S. government’s directive to halt the President’s Emergency Plan for AIDS Relief (PEPFAR), which would have disrupted the supply of antiviral medications for millions.

The Trump administration has made some concessions to the halt placed on distributions of global HIV treatments via the U.S. President's Emergency Plan for AIDS Relief (PEPFAR), according to The New York Times.

The United States Secretary of State, Marco Rubio, has approved an "Emergency Humanitarian Waiver" allowing continued access to US-funded HIV treatment across 55 countries.

It is estimated that PEPFAR supports treatment for over 20 million people living with HIV, accounting for two-thirds of all people globally receiving HIV treatment